Investigating how TRPM7 influences tumor growth and stem cell properties in gliomas
TRPM7 induces tumorigenesis and stemness through Notch activation in glioma
This study is looking at how a protein called TRPM7 affects brain cancer cells, specifically gliomas, to find new ways to help patients with this tough condition by understanding how it influences tumor growth and treatment resistance.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Morehouse School of Medicine NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11044187 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of TRPM7, a specific protein, in the development and aggressive behavior of gliomas, a type of brain cancer. It examines how TRPM7 affects Notch signaling pathways, which are crucial for maintaining the stem-like characteristics of glioma stem cells. By exploring the mechanisms through which TRPM7 influences tumor growth and resistance to standard treatments, the research aims to identify new therapeutic targets that could improve outcomes for patients with glioblastomas. The study involves laboratory experiments using glioma cell lines to assess the effects of TRPM7 suppression on tumor behavior.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who have not responded well to current treatment options.
Not a fit: Patients with non-cancerous brain conditions or those with glioblastoma who are in advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies that more effectively target glioblastomas and improve patient survival rates.
How similar studies have performed: Previous research has shown promising results in targeting similar pathways in gliomas, suggesting that this approach could be effective.
Where this research is happening
Atlanta, United States
- Morehouse School of Medicine — Atlanta, United States (Active)
Researchers
- Principal investigator: Liu, Mingli — Morehouse School of Medicine
- Study coordinator: Liu, Mingli
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.